Essential cross-linking role for FcgRIIB in the in vivo activity of anti-CD40 monoclonal antibody

被引:0
|
作者
White, A. L. [1 ]
Chan, H. T. C. [1 ]
French, R. R. [1 ]
Roghanian, A. [1 ]
Mockridge, C. I. [1 ]
Tutt, A. L. [1 ]
Verbeek, J. S. [2 ]
Noelle, R. J. [3 ]
Al-Shamkhani, A. [1 ]
Cragg, M. S. [1 ]
Beers, S. A. [1 ]
Glennie, M. J. [1 ]
机构
[1] Univ Southampton, Fac Med, Southampton SO9 5NH, Hants, England
[2] Leiden Univ, Med Ctr, Leiden, Netherlands
[3] Kings Coll London, MRC, Ctr Transplantat, London WC2R 2LS, England
关键词
D O I
暂无
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
引用
收藏
页码:189 / 189
页数:1
相关论文
共 50 条
  • [21] Cancer immunotherapy with a chimeric anti-CD40 monoclonal antibody: Evidence of preclinical efficacy.
    Or, R
    Ackerstein, A
    Morecki, S
    Gelfand, Y
    Samuel, S
    Slavin, S
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 182S - 182S
  • [22] Characterization of a Broadly Reactive Anti-CD40 Agonistic Monoclonal Antibody for Potential Use as an Adjuvant
    Martin, Cameron
    Waghela, Suryakant D.
    Lokhandwala, Shehnaz
    Ambrus, Andy
    Bray, Jocelyn
    Vuong, Christina
    Vinodkumar, Vanitha
    Dominowski, Paul J.
    Rai, Sharath
    Mwangi, Duncan
    Foss, Dennis L.
    Mwangi, Waithaka
    PLOS ONE, 2017, 12 (01):
  • [23] Anti-CD40 antibody induces antitumor and antimetastatic effects: The role of NK cells
    Turner, JG
    Rakhmilevich, AL
    Burdelya, C
    Neal, Z
    Imboden, M
    Sondel, PM
    Yu, H
    JOURNAL OF IMMUNOLOGY, 2001, 166 (01): : 89 - 94
  • [24] Anti-CD40 ligand antibody and anti-CD40 isotype IgG2B antibody induce equivalent murine chimerism and skin graft tolerance unlike anti-CD40 isotype IgG1 antibody.
    Milas, ZL
    Adams, AB
    Jones, T
    Durham, M
    Pearson, TC
    Larsen, CP
    AMERICAN JOURNAL OF TRANSPLANTATION, 2004, 4 : 581 - 581
  • [25] Concurrent Ocular and Cerebral Toxoplasmosis in a Liver Transplant Patient Treated with Anti-CD40 Monoclonal Antibody
    van den Noortgate, Roos
    Kiselinova, Maja
    Sys, Celine
    Accou, Geraldine
    Laureys, Guy
    Van Vlierberghe, Hans
    Berrevoet, Frederik
    Kreps, Elke O.
    CASE REPORTS IN INFECTIOUS DISEASES, 2023, 2023
  • [26] Tuberculosis dissemination in kidney transplant recipient treated with anti-CD40 monoclonal antibody: a case report
    Bednarova, Kamila
    Slatinska, Janka
    Fabian, Ondrej
    Wohl, Pavel
    Kopecka, Emilia
    Viklicky, Ondrej
    BMC NEPHROLOGY, 2022, 23 (01)
  • [27] A phase I humanized Anti-CD40 monoclonal antibody (SGN-40) in patients with multiple myeloma.
    Hussein, MA
    Berenson, JR
    Niesvizky, R
    Munshi, NC
    Harrop, KL
    McDonald, M
    Drachman, JG
    BLOOD, 2005, 106 (11) : 723A - 723A
  • [28] Precision Medicine in Graves' Disease: CD40 Gene Variants Predict Clinical Response to an Anti-CD40 Monoclonal Antibody
    Faustino, Larissa C.
    Kahaly, George J.
    Frommer, Lara
    Concepcion, Erlinda
    Stefan-Lifshitz, Mihaela
    Tomer, Yaron
    FRONTIERS IN ENDOCRINOLOGY, 2021, 12
  • [29] Tuberculosis dissemination in kidney transplant recipient treated with anti-CD40 monoclonal antibody: a case report
    Kamila Bednarova
    Janka Slatinska
    Ondrej Fabian
    Pavel Wohl
    Emilia Kopecka
    Ondrej Viklicky
    BMC Nephrology, 23
  • [30] A humanized anti-cd40 antibody with anti-tumor pharmacological activity and cynomolgus monkey safety
    Li, Zhenyu
    Zhao, Lili
    Zhang, Guimin
    Li, Bin
    Liu, Zhong
    Li, Guangyan
    Zhu, Zhongsong
    CANCER RESEARCH, 2023, 83 (07)